Synthetic Biology
Sherlock Biosciences Receives $5M Gates Foundation Grant for COVID-19 Self-Test
The funding will help the company further develop its INSPECTR molecular diagnostic platform into a test that can be used in various settings.
Two new grants are helping the company develop its SHERLOCK and INSPECTR technologies as the basis for creating innovative diagnostics.
Agilent Teams Up With Singapore University, Hospital for New $38M Hub for Clinical Diagnostics
Agilent has partnered with the National University of Singapore and National University Hospital to establish the S$38 million ($27.4 million) research and development facility in Singapore.
Piper Jaffray Initiates Coverage of Danaher, Agilent
The investment bank gave Danaher a Neutral rating and a $148 price target on the firm's shares, while it gave Agilent an Overweight rating with an $83 price target.
Sherlock Biosciences Closes $31M Series A Financing Round
The company launched last month with initial financing of $35 million and licenses to CRISPR and synthetic biology technology from the Broad and Harvard.